Search research resources and analytical documentation published or approved by Aurelius Labs.
Sikiric P, et al. “Stable gastric pentadecapeptide BPC 157 in the treatment of tendon, ligament and muscle healing.” Curr Pharm Des. 2018;24(18):1990–2001. Preclinical literature describing wound-healing and angiogenesis endpoints in animal models. Research use only; no clinical claims.
Lee C, et al. “The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.” Cell Metab. 2015;21(3):443–454. Describes the role of MOTS-c in metabolic regulation in rodent models.
Pickart L, Margolina A. “Regenerative and protective actions of the GHK-Cu peptide.” Int J Mol Sci. 2018;19(7):1987. Reviews extracellular-matrix and dermal research on the copper-binding tripeptide.
Batch content (mg) and chromatographic purity (%) are measured by Janoshik Analytical and reported per vial. Each published assay states the reporting laboratory, method and date — see the COA library.
For incretin analogs, a blind panel screens a sample against semaglutide, tirzepatide and retatrutide without prior disclosure to the laboratory, confirming identity alongside content. Applied to the RT GLP3 batch.
Every published batch report is searchable by product, task number, batch and verification key in the COA library, and can be confirmed at source with Janoshik Analytical.
